Biotage AB (publ)
BITGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,056 | $1,862 | $1,566 | $1,232 |
| % Growth | 10.4% | 18.9% | 27.1% | – |
| Cost of Goods Sold | $767 | $713 | $618 | $477 |
| Gross Profit | $1,289 | $1,149 | $948 | $755 |
| % Margin | 62.7% | 61.7% | 60.5% | 61.3% |
| R&D Expenses | $180 | $159 | $109 | $91 |
| G&A Expenses | $235 | $194 | $150 | $117 |
| SG&A Expenses | $704 | $597 | $529 | $404 |
| Sales & Mktg Exp. | $469 | $403 | $379 | $287 |
| Other Operating Expenses | $22 | $79 | -$17 | -$11 |
| Operating Expenses | $906 | $835 | $621 | $484 |
| Operating Income | $383 | $314 | $327 | $271 |
| % Margin | 18.6% | 16.9% | 20.9% | 22% |
| Other Income/Exp. Net | -$55 | -$11 | $21 | -$2 |
| Pre-Tax Income | $328 | $303 | $348 | $269 |
| Tax Expense | $44 | $57 | $80 | $64 |
| Net Income | $284 | $246 | $268 | $205 |
| % Margin | 13.8% | 13.2% | 17.1% | 16.6% |
| EPS | 3.55 | 0.33 | 0.39 | 0.35 |
| % Growth | 975.8% | -15.4% | 11.4% | – |
| EPS Diluted | 3.55 | 0.33 | 0.39 | 0.34 |
| Weighted Avg Shares Out | 80 | 74 | 66 | 65 |
| Weighted Avg Shares Out Dil | 80 | 74 | 66 | 65 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $9 | $2 | $0 |
| Interest Expense | $43 | $41 | $5 | $3 |
| Depreciation & Amortization | $185 | $149 | $101 | $75 |
| EBITDA | $530 | $465 | $454 | $347 |
| % Margin | 25.8% | 25% | 29% | 28.2% |